Chiusura precedente | 3,5300 |
Aperto | 3,5200 |
Denaro | 3,4000 x 0 |
Domanda | 3,4300 x 0 |
Min-Max giorno | 3,4000 - 3,5200 |
Intervallo di 52 settimane | 2,1450 - 4,2800 |
Volume | |
Media Volume | 262.385 |
Capitalizzazione | 1,31B |
Beta (mensile su 5 anni) | 1,02 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -0,1900 |
Prossima data utili | 06 ago 2024 - 12 ago 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 4,02 |
TORONTO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is pleased to announce its Spinach® brand won “Best Pre-Roll” at the Grow Up Awards this past Sunday for its Spinach® Fully Charged Atomic GMO infused pre-rolls. The annual Grow Up Awards celebrate excellence in the cannabis industry, recognizing outstanding achievements and innovation in a variety of cannabis-related categories. “Spinach® pre-rolls are de
TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group (“Cansativa”), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis
Cronos Labs has also signed up Google Cloud, Amazon Web Services and blockchain security specialists PeckShield and Certik as mentors for the program.